SUPRIYA TOLANI: Open Payments
NPI 1164126686 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$83 in 3 payments from 3 companies in 2025. Trend: 2023 $36 · 2024 $0 · 2025 $83
Food & beverage: $83
| Company | Payments | Amount |
|---|---|---|
| Alnylam Pharmaceuticals Inc. | 1 | $32 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| Melinta Therapeutics, LLC | 1 | $21 |
Products named: AMVUTTRA, KEYTRUDA, Rezzayo.
Industry payments across NY — which companies pay providers there.
